StemCells (STEM) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts STEM Hot Sheet
Price: $4.60 -2.54%
Revenue Growth %: +9.3%
Financial Fact:
Total operating expenses: 8.91M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +9.3%
Financial Fact:
Total operating expenses: 8.91M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
StemCells (NASDAQ: STEM) reported Q4 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $28 thousand versus the consensus estimate of $30 thousand.
For earnings history and earnings-related data on StemCells (STEM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Arrive AI and DXC Technology partner to bring delivery tech to factories
- Barclays says AI trade is maturing, favors greater diversification
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
